Loading...
Market
AstraZeneca stock price movement post-lawsuit announcement
5
Resolution / Starting Odds
Increase • 33%
Decrease • 33%
No significant change • 34%
Stock market data
Story
Utah Woman Files First U.S. Lawsuit Against AstraZeneca Over Permanent COVID-19 Vaccine Injury
May 14, 2024, 01:33 PM
Brianne Dressen, a 42-year-old former teacher and mom from Utah, has filed the first U.S. lawsuit against AstraZeneca. Dressen, who participated in the U.S. clinical trial of the AstraZeneca COVID-19 vaccine, alleges that the vaccine left her permanently disabled. She claims that AstraZeneca breached its contract by not covering the medical care she requires to deal with her injury. The lawsuit was filed on May 13.
View original story
Similar markets
Stock prices increase • 33%
Stock prices decrease • 33%
No significant change in stock prices • 34%
Stock price increases • 33%
Stock price decreases • 33%
Stock price remains stable • 34%
Increase by 5% or more • 33%
Decrease by 5% or more • 33%
No significant change • 33%
No significant change • 33%
Decrease in stock prices • 33%
Increase in stock prices • 33%
Increase • 33%
Decrease • 33%
Remain stable • 34%
Stock price rises • 33%
Stock price falls • 33%
Stock price remains stable • 34%
CBS stock price increases • 50%
CBS stock price decreases • 50%
Increase by more than 5% • 33%
Decrease by more than 5% • 33%
No significant change • 33%
Increase in market value • 33%
Decrease in market value • 33%
No significant change • 33%